Among the TomoHDA System’s numerous benefits are streamlined daily 3D CT image guidance for accurate treatment delivery, faster treatment times, and the ability to create treatment plans that specifically target the cancer while sparing the surrounding healthy tissue. The TomoHDA now only allows cancer treatment centers to treat more patients daily, but also to maintain the patient’s quality of life as much as possible.
Daron Street M.D. of the Tulsa Cancer Institute said, “The flexibility of the TomoHDA System allows our physicians to not only treat common cancers but also tackle more complicated cancers in the most efficient, accurate way possible.” This should offer their patients the opportunity for the best possible clinical outcomes.
Accuray is a radiation oncology company that develops, manufactures, and sells innovative treatment solutions that set the standard of care in helping patients live longer, healthier lives. The company’s leading edge technologies deliver the full range of radiation therapy and radiosurgery treatments.
For additional information about Accuray, visit www.accuray.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
